Male infertility has seen significant advancements in diagnostics and treatment over the past decades, including assisted reproductive technologies, sperm selection techniques, and novel sperm function tests. However, further research is needed to address the remaining gaps in understanding the causes of male infertility and to develop effective treatments. This review discusses recent developments in male infertility management, such as oxidative stress testing, sperm DNA fragmentation analysis, genetic and epigenetic testing, artificial intelligence, personalized medicine, and telemedicine. The role of reproductive urologists is expected to expand in the future to address various aspects of male infertility, including pathophysiology, diagnosis, and therapy, as well as training researchers and physicians in reproductive urology and andrology. Male infertility is influenced by a variety of factors, including environmental, genetic, inflammatory, infectious, drug-induced, and hormonal disorders, as well as anatomical issues such as varicoceles. Varicoceles are the most common correctable cause of male infertility, with a significant impact on testicular function. Recent studies have shown that varicocele repair can improve semen parameters, although the long-term effects on testosterone production remain controversial. Environmental factors, such as pollution and endocrine-disrupting chemicals, also contribute to the decline in semen quality. Additionally, lifestyle factors like smoking, e-cigarette use, and obesity have been linked to reduced sperm count and quality. The 6th edition of the WHO manual for semen analysis provides updated guidelines for the initial assessment of infertile couples, including the use of semen analysis and the absence of recommended reference values. The manual emphasizes the importance of using the 5th percentile values for semen parameters, but highlights the need for further research to determine their clinical utility. Artificial intelligence is being explored for its potential in improving sperm analysis and selection, with studies showing promising results in predicting sperm parameters and improving the accuracy of sperm motility assessments. Home testing of semen has also gained attention, with various products available for at-home sperm testing. These products offer convenience but may lack the accuracy and comprehensiveness of laboratory-based tests. Whole genome testing and epigenetic markers are being developed to improve the diagnosis and treatment of male infertility, particularly in cases of non-obstructive azoospermia. Seminal proteomics and radiomics are also emerging as valuable tools in understanding and managing male infertility. The relationship between male fertility and general health is increasingly recognized, with studies showing that infertile men have a higher risk of mortality and comorbidities. Personalized medicine, including stem cell therapy, gene therapy, and nanoparticle drug delivery, is being explored as potential treatments for male infertility. Fertility preservation techniques, such as sperm cryopreservation and testicular tissue cryopreservation, are being developed to help men undergoing gonadotoxic therapies. The future of andrology is expected to involve greater collaboration among researchers and clinicians, with international initiatives aimed at improving the understanding and management of male infertility. The roleMale infertility has seen significant advancements in diagnostics and treatment over the past decades, including assisted reproductive technologies, sperm selection techniques, and novel sperm function tests. However, further research is needed to address the remaining gaps in understanding the causes of male infertility and to develop effective treatments. This review discusses recent developments in male infertility management, such as oxidative stress testing, sperm DNA fragmentation analysis, genetic and epigenetic testing, artificial intelligence, personalized medicine, and telemedicine. The role of reproductive urologists is expected to expand in the future to address various aspects of male infertility, including pathophysiology, diagnosis, and therapy, as well as training researchers and physicians in reproductive urology and andrology. Male infertility is influenced by a variety of factors, including environmental, genetic, inflammatory, infectious, drug-induced, and hormonal disorders, as well as anatomical issues such as varicoceles. Varicoceles are the most common correctable cause of male infertility, with a significant impact on testicular function. Recent studies have shown that varicocele repair can improve semen parameters, although the long-term effects on testosterone production remain controversial. Environmental factors, such as pollution and endocrine-disrupting chemicals, also contribute to the decline in semen quality. Additionally, lifestyle factors like smoking, e-cigarette use, and obesity have been linked to reduced sperm count and quality. The 6th edition of the WHO manual for semen analysis provides updated guidelines for the initial assessment of infertile couples, including the use of semen analysis and the absence of recommended reference values. The manual emphasizes the importance of using the 5th percentile values for semen parameters, but highlights the need for further research to determine their clinical utility. Artificial intelligence is being explored for its potential in improving sperm analysis and selection, with studies showing promising results in predicting sperm parameters and improving the accuracy of sperm motility assessments. Home testing of semen has also gained attention, with various products available for at-home sperm testing. These products offer convenience but may lack the accuracy and comprehensiveness of laboratory-based tests. Whole genome testing and epigenetic markers are being developed to improve the diagnosis and treatment of male infertility, particularly in cases of non-obstructive azoospermia. Seminal proteomics and radiomics are also emerging as valuable tools in understanding and managing male infertility. The relationship between male fertility and general health is increasingly recognized, with studies showing that infertile men have a higher risk of mortality and comorbidities. Personalized medicine, including stem cell therapy, gene therapy, and nanoparticle drug delivery, is being explored as potential treatments for male infertility. Fertility preservation techniques, such as sperm cryopreservation and testicular tissue cryopreservation, are being developed to help men undergoing gonadotoxic therapies. The future of andrology is expected to involve greater collaboration among researchers and clinicians, with international initiatives aimed at improving the understanding and management of male infertility. The role